Oryzon Genomics SA (ORYZF)

3.31 0.00 (0.00%) USD  |  OTCM  |  Sep 17, 16:00
More

Oryzon Genomics Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for ORYZF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to . Start Trial.
Date Value

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Pharma Mar SA Upgrade
Grifols SA Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alkermes Plc Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade